Literature DB >> 33339256

N-Terminal Tagging with GFP Enhances Selectivity of Agitoxin 2 to Kv1.3-Channel Binding Site.

Oksana V Nekrasova1, Alexandra L Primak1,2, Anastasia A Ignatova1, Valery N Novoseletsky2, Olga V Geras'kina2, Ksenia S Kudryashova1,2, Sergey A Yakimov1, Mikhail P Kirpichnikov1,2, Alexander S Arseniev1, Alexey V Feofanov1,2.   

Abstract

Recently developed fluorescent protein-scorpion toxin chimeras (FP-Tx) show blocking activities for potassium voltage-gated channels of Kv1 family and retain almost fully pharmacological profiles of the parental peptide toxins (Kuzmenkov et al., Sci Rep. 2016, 6, 33314). Here we report on N-terminally green fluorescent protein (GFP)-tagged agitoxin 2 (GFP-L2-AgTx2) with high affinity and selectivity for the binding site of Kv1.3 channel involved in the pathogenesis of various (primarily of autoimmune origin) diseases. The basis for this selectivity relates to N-terminal location of GFP, since transposition of GFP to the C-terminus of AgTx2 recovered specific interactions with the Kv1.1 and Kv1.6 binding sites. Competitive binding experiments revealed that the binding site of GFP-L2-AgTx2 overlaps that of charybdotoxin, kaliotoxin 1, and agitoxin 2, the known Kv1.3-channel pore blockers. GFP-L2-AgTx2 was demonstrated to be applicable as a fluorescent probe to search for Kv1.3 pore blockers among individual compounds and in complex mixtures, to measure blocker affinities, and to visualize Kv1.3 distribution at the plasma membrane of Kv1.3-expressing HEK293 cells. Our studies show that definite combinations of fluorescent proteins and peptide blockers can result in considerable modulation of the natural blocker-channel binding profile yielding selective fluorescent ligands of certain channels.

Entities:  

Keywords:  GFP; agitoxin; potassium channel; selective ligand

Mesh:

Substances:

Year:  2020        PMID: 33339256      PMCID: PMC7766132          DOI: 10.3390/toxins12120802

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   4.546


  29 in total

1.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

Review 2.  Enhancing the therapeutic potential of peptide toxins.

Authors:  Raymond S Norton
Journal:  Expert Opin Drug Discov       Date:  2017-04-20       Impact factor: 6.098

3.  Fluorescent system based on bacterial expression of hybrid KcsA channels designed for Kv1.3 ligand screening and study.

Authors:  Kseniya S Kudryashova; Oksana V Nekrasova; Alexey I Kuzmenkov; Alexander A Vassilevski; Anastasia A Ignatova; Yuliya V Korolkova; Eugene V Grishin; Mikhail P Kirpichnikov; Alexey V Feofanov
Journal:  Anal Bioanal Chem       Date:  2013-01-11       Impact factor: 4.142

Review 4.  Progress in Research of KV1.1 and KV1.3 Channels as Therapeutic Targets.

Authors:  Wei Zhao; Yuan Chen
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 5.  Labelled animal toxins as selective molecular markers of ion channels: Applications in neurobiology and beyond.

Authors:  Alexey I Kuzmenkov; Alexander A Vassilevski
Journal:  Neurosci Lett       Date:  2017-11-22       Impact factor: 3.046

6.  Synthesis, characterization, and application of cy-dye- and alexa-dye-labeled hongotoxin(1) analogues. The first high affinity fluorescence probes for voltage-gated K+ channels.

Authors:  Bernt Pragl; Alexandra Koschak; Maria Trieb; Gerald Obermair; Walter A Kaufmann; Uli Gerster; Eric Blanc; Christoph Hahn; Heino Prinz; Gerhard Schütz; Herve Darbon; Hermann J Gruber; Hans-Günther Knaus
Journal:  Bioconjug Chem       Date:  2002 May-Jun       Impact factor: 4.774

7.  Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom.

Authors:  M L Garcia; M Garcia-Calvo; P Hidalgo; A Lee; R MacKinnon
Journal:  Biochemistry       Date:  1994-06-07       Impact factor: 3.162

8.  Variability of Potassium Channel Blockers in Mesobuthus eupeus Scorpion Venom with Focus on Kv1.1: AN INTEGRATED TRANSCRIPTOMIC AND PROTEOMIC STUDY.

Authors:  Alexey I Kuzmenkov; Alexander A Vassilevski; Kseniya S Kudryashova; Oksana V Nekrasova; Steve Peigneur; Jan Tytgat; Alexey V Feofanov; Mikhail P Kirpichnikov; Eugene V Grishin
Journal:  J Biol Chem       Date:  2015-03-19       Impact factor: 5.157

9.  Straightforward approach to produce recombinant scorpion toxins-Pore blockers of potassium channels.

Authors:  Oksana Nekrasova; Ksenia Kudryashova; Arkadiy Fradkov; Sergey Yakimov; Maria Savelieva; Mikhail Kirpichnikov; Alexey Feofanov
Journal:  J Biotechnol       Date:  2016-11-30       Impact factor: 3.307

10.  A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes.

Authors:  Christine Beeton; Heike Wulff; Satendra Singh; Steve Botsko; George Crossley; George A Gutman; Michael D Cahalan; Michael Pennington; K George Chandy
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

View more
  3 in total

1.  GFP-Margatoxin, a Genetically Encoded Fluorescent Ligand to Probe Affinity of Kv1.3 Channel Blockers.

Authors:  Kristina R Denisova; Nikita A Orlov; Sergey A Yakimov; Elena A Kryukova; Dmitry A Dolgikh; Mikhail P Kirpichnikov; Alexey V Feofanov; Oksana V Nekrasova
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

2.  Snake Toxins Labeled by Green Fluorescent Protein or Its Synthetic Chromophore are New Probes for Nicotinic acetylcholine Receptors.

Authors:  Igor E Kasheverov; Alexey I Kuzmenkov; Denis S Kudryavtsev; Ivan S Chudetskiy; Irina V Shelukhina; Evgeny P Barykin; Igor A Ivanov; Andrei E Siniavin; Rustam H Ziganshin; Mikhail S Baranov; Victor I Tsetlin; Alexander A Vassilevski; Yuri N Utkin
Journal:  Front Mol Biosci       Date:  2021-11-30

3.  Atto488-Agitoxin 2-A Fluorescent Ligand with Increased Selectivity for Kv1.3 Channel Binding Site.

Authors:  Kristina R Denisova; Nikita A Orlov; Sergey A Yakimov; Mikhail P Kirpichnikov; Alexey V Feofanov; Oksana V Nekrasova
Journal:  Bioengineering (Basel)       Date:  2022-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.